1. Current insights into the metastasis of epithelial ovarian cancer - hopes and hurdles
   Meysam Yousefi et al, 2020, Cellular Oncology CrossRef
2. Histone deacetylases as new therapy targets for platinum-resistant epithelial ovarian cancer
   Dmitri Pchejetski et al, 2016, Journal of Cancer Research and Clinical Oncology CrossRef
3. Involvement of GRP78 in the Resistance of Ovarian Carcinoma Cells to Paclitaxel
   Li-Ying Zhang et al, 2015, Asian Pacific Journal of Cancer Prevention CrossRef
4. Testing Doses and Treatment Timelines of Anti-Angiogenic Drug Bevacizumab Numerically as a Single-Agent for the Treatment of Ovarian Cancer
   Dharma Raj Khatiwada et al, 2023, Mathematics CrossRef
5. Oxaliplatin plus leucovorin and 5-fluorouracil (FOLFOX-4) as a salvage chemotherapy in heavily-pretreated platinum-resistant ovarian cancer
   Vincenza Conteduca et al, 2018, BMC Cancer CrossRef
6. Phase II trial of bevacizumab and sorafenib in recurrent ovarian cancer patients with or without prior-bevacizumab treatment
   Jung-Min Lee et al, 2020, Gynecologic Oncology CrossRef
7. MicroRNA-497 suppresses angiogenesis by targeting vascular endothelial growth factor A through the PI3K/AKT and MAPK/ERK pathways in ovarian cancer
   WEI WANG et al, 2014, Oncology Reports CrossRef
8. GRP78: A cell's response to stress
   Ibrahim M. Ibrahim et al, 2019, Life Sciences CrossRef
9. Prognostic values of 5-hmC, 5-mC and TET2 in epithelial ovarian cancer
   Li-ying Zhang et al, 2015, Archives of Gynecology and Obstetrics CrossRef
10. Novel Anti-Angiogenic and Anti-Tumour Activities of the N-Terminal Domain of NOEY2 via Binding to VEGFR-2 in Ovarian Cancer
    Seung Bae Rho et al, 2021, Biomolecules & Therapeutics CrossRef
11. Biological Pathways Involved in Tumor Angiogenesis and Bevacizumab Based Anti-Angiogenic Therapy with Special References to Ovarian Cancer
    Vera Loizzi et al, 2017, International Journal of Molecular Sciences CrossRef
12. Retracted: Blockade of ONECUT2 expression in ovarian cancer inhibited tumor cell proliferation, migration, invasion and angiogenesis
    Tongyi Lu et al, 2018, Cancer Science CrossRef
13. Melphalan as a Promising Treatment for BRCA-Related Ovarian Carcinoma
    Vincenza Conteduca et al, 2021, Frontiers in Oncology CrossRef
14. Editorial: Altered Expression of Proteins in Cancer: Function and Potential Therapeutic Targets
    João Pessoa et al, 2022, Frontiers in Oncology CrossRef
15. Observation of the therapeutic effect of apatinib in advanced platinum-resistant recurrent epithelial ovarian cancer
    Zhongmian Pan et al, 2023, Journal of Ovarian Research CrossRef
16. Interference with the Expression of β-Catenin Reverses Cisplatin Resistance in A2780/DDP Cells and Inhibits the Progression of Ovarian Cancer in Mouse Model
    Hongmin Zhao et al, 2015, DNA and Cell Biology CrossRef